Wed, 11 Nov 2015 14:15:00 GMT ~ Groupe Athena, Inc. Announces Revenue Update
[Accesswire] - MUMBAI, INDIA / ACCESSWIRE / November 11, 2015 / Groupe Athena, Inc. (OTC Pink: GATA) (PINKSHEETS: GATA) announced on November 11, 2015 that based on the orders in hand, the company expects to achieve ...
Tue, 10 Nov 2015 13:51:00 GMT ~ Groupe Athena Required Due Diligence for Investors - Broad Street Alerts
[Accesswire] - NEW YORK, NY / ACCESSWIRE / November 10, 2015 / Groupe Athena Inc. (OTCBB: GATA) shares closed yesterday at $.14 down 6.67% following the release of first quarter financial results Trading volume was 35,000 ...
Mon, 09 Nov 2015 14:15:00 GMT ~ Groupe Athena, Inc. Posts Strong 1st Quarter Results
[Accesswire] - MUMBAI, INDIA / ACCESSWIRE / November 9, 2015 / Groupe Athena, Inc. (PINKSHEETS: GATA) today announced revenues of $22,672,908 for the period ending September 30, 2015, which represents an increase of ...
Link: http://www.otcmarkets.com/stock/GATA/company-info Ticker: $GATA OTC Market Place: OTC Pink Current CIK code: 0001486095 Company name: Groupe Athena Inc. Company website: http://www.groupeathena.com Incorporated In: NJ, USA
Business Description: Serving India and South East Asia, Groupe Athena has been serving companies abroad in obtaining FDA approval for pharmaceuticals, medical products and devices for export to the USA. Our goal is to ensure each of our clients passes FDA inspection by assisting them from concept through development, with consultation through all the regulatory requirements, filings, and processes to achieve FDA compliance and approval.With offices in India and America, the expert consultants of Groupe Athena are in position to go to American target companies and the regulatory authorities directly, consulting with our clients in the East to serve them completely in providing consultancy services for FDA compliance. Services include providing technical and regulatory consulting for biotechnical products, pharmaceuticals [over the counter, prescription and generics], diagnostics, medical equipment, and devices.The FDA inspection process is traditionally complicated, especially for foreign drug and medical companies trying to export to the USA. With broad spectrum consultancy and assistance through this process, our client base can count on reduced risk, follow-through on steps necessary for FDA compliance and identifying and solving breaches in compliance.From concept through final approval, Groupe Athena navigates companies through every requirement of the process including pharmaceutical consulting, development, and regulatory compliance to achieve FDA approval and export pharmaceuticals and medical products and equipment to the USA.Services Offered:Analytical QCQA FunctionsReadiness for InspectionsComplianceValidationClinical Trial ManagementRegulatory/LegalPreparation of Regulatory Filings (IND's/PMA's/NDA's/ANDA's/510Ks etc)Compliance Assessments (GLP, GMP, GXP)Risk AssessmentsMock FDA AuditsMedical Device SupportCMC SupportGMP TrainingFacility Layout ConsultingUtilities, Process, IT, Computer, and Cleaning ValidationTrainingLess >>
News 
Market Data 
Discover 
